PPD

PPD Other Income/Expense

Delisted

The Other Income/Expense (Net) of PPD (PPD) as of Nov 5, 2026 is 321.88 M USD. In the previous year, Other Income/Expense (Net) was 359.21 M USD — a change of -10.39% (lower).

Other Income/Expense

321.88 MUSD

YoY

-10.39%

Last updated:

Other Income/Expense (Net) of PPD is 2020 321.88 M USD. Other Income/Expense (Net) of PPD was 2019 359.21 M USD. It decreases by -10.39% lower compared to the previous year.

The PPD Other Income/Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Other Income/Expense
Date
Other Income/Expense
Jan 1, 2016
147.37 M USD
Jan 1, 2017
244.86 M USD
Jan 1, 2018
255.61 M USD
Jan 1, 2019
359.21 M USD
Jan 1, 2020
321.88 M USD
The PPD Other Income/Expense history
YEAROther Income/ExpenseYoY
321.88 MUSD-10.39%
359.21 MUSD+40.53%
255.61 MUSD+4.39%
244.86 MUSD+66.15%
147.37 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PPD Stock analysis

What does PPD do? PPD Inc is a global company for medical research and services that was founded in 1985 and is headquartered in Wilmington, North Carolina, USA. The company is known for its ability to conduct clinical trials and develop research programs for the biopharmaceutical and medical industry. PPD is a leading provider of comprehensive, integrated services for phases I-IV of clinical research, from non-interventional studies to contract research for pharmaceutical and biotech clients. PPD's business model is based on three key pillars to provide customers with a broad portfolio of services: the first pillar is comprehensive clinical research required for drug registration with regulatory authorities, the second pillar focuses on providing research-based data and analytical methods to facilitate decision-making and risk assessment in the healthcare sector, and the third pillar encompasses extensive laboratory analyses and diagnostic tests to improve patient health and support research efforts. PPD has multiple divisions focused on specific markets and customers. The Clinical Trials division offers services for drug development up to approval by regulatory authorities, including the setup and monitoring of clinical trials and statistical analysis of test results. The Data Management division provides data capture and management solutions for clinical trials to ensure high data quality and compliance with regulations. The Medical Monitoring division offers medical consultation and monitoring during clinical trials. PPD also has a division for Real World Evidence studies, which collects data from routine clinical practice to assess the safety and efficacy of drugs. PPD has made some important acquisitions in the past to strengthen its presence in the industry. In 2011, PPD was acquired by private equity firms Carlyle Group and Hellman & Friedman, becoming a private company. In 2020, PPD went public. In 2018, PPD acquired Evidera, a company specializing in clinical epidemiology and outcomes research. In 2019, PPD acquired Q-Squared Solutions, expanding its extensive laboratory analysis and diagnostic testing capabilities. PPD's offerings include a wide range of products and services, including unique planning and implementation solutions that enable efficient conduct of clinical trials. These solutions also include electronic data capture and management systems, as well as statistical analysis tools. PPD also offers specialized services, such as training programs for clinical investigators and staff. PPD aims to enable safe, faster, and cost-effective drug development through clinical research. In the future, PPD will continue to expand its business model and services to meet the needs of its customers in the changing industry and support innovative research programs. PPD is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PPD stock

Other Income/Expense (Net) of PPD is 321.88 M USD in 2020.

Other Income/Expense (Net) of PPD changed from 359.21 M USD to 321.88 M USD, representing a -10.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Other Income/Expense (Net) PPD since 2006 – with annual values, charts, and detailed analysis.

Other income and expense includes non-operating items such as gains/losses on investments, foreign exchange, and other non-core activities.

Other Income/Expense (Net)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Other Income/Expense (Net)'s PPD historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — PPD

All Key Metrics — PPD